The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience.

The cardiovascular safety of diabetes drugs--insights from the rosiglitazone experience.

The New England journal of medicine (2013-09-03)

William R Hiatt, Sanjay Kaul, Robert J Smith

材料

产品编号

品牌

产品描述

Sigma-Aldrich

罗格列酮, ≥98% (HPLC)